Showing results (81-90 of 212) with videos related to

Sort By:
Pageof 22
The Oncologist|December 21, 2020
Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic CancerDaniel D Von Hoff, Derek Cridebring, Olivia Yu Tian, et al.
Molecular Cancer Therapeutics|August 8, 2006
Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approachSteven L Warner, Sridevi Bashyam, Hariprasad Vankayalapati, et al.
Plos One|March 8, 2012
Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cellsCaroline H Diep, Kelly M Zucker, Galen Hostetter, et al.
Clinical Genitourinary Cancer|February 15, 2008
Phase II study of azacitidine to restore responsiveness of prostate cancer to hormonal therapyGuru Sonpavde, Ana Aparicio, Israel Guttierez, et al.
Molecular Cancer Research : MCR|December 21, 2010
Functional genomics reveals diverse cellular processes that modulate tumor cell response to oxaliplatinKelly A Harradine, Michelle Kassner, Donald Chow, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 5, 2017
18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancerRonald L Korn, Daniel D Von Hoff, Mitesh J Borad, et al.
British Journal of Cancer|June 6, 2018
Safety, pharmacokinetics, and preliminary efficacy of E6201 in patients with advanced solid tumours, including melanoma: results of a phase 1 studyRaoul Tibes, Mitesh J Borad, Corina E Dutcus, et al.
Journal of the Advanced Practitioner in Oncology|February 16, 2026
Empowering Research Leadership: Development of an Intensive Course to Support Oncology Advanced Practitioner Participation in Clinical TrialsCarol Guarnieri, Gayle Jameson, Stephanie Franz, et al.
Frontiers in Pharmacology|February 2, 2013
Clonal evolution and therapeutic resistance in solid tumorsMichael T Barrett, Elizabeth Lenkiewicz, Lisa Evers, et al.
American Journal of Clinical Oncology|April 9, 2008
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trialTomislav Dragovich, Howard Burris, Patrick Loehrer, et al.
Pageof 22